Anaphylactic Shock: Mechanisms and Treatment 12, 89-100 A.F.T

Total Page:16

File Type:pdf, Size:1020Kb

Anaphylactic Shock: Mechanisms and Treatment 12, 89-100 A.F.T Journal of REVIEW ARTICLE Accident and J Accid Emerg Med: first published as 10.1136/emj.12.2.89 on 1 June 1995. Downloaded from Emergency Medicine 1995 Anaphylactic shock: mechanisms and treatment 12, 89-100 A.F.T. BROWN Department of Emergency Medicine, Royal Brisbane Hospital, Brisbane, Queensland, Australia introduced the term 'allergy' although he assumed SUMMARY that the major allergic diseases, such as urticaria This paper reviews the mechanisms of and asthma, were due to the absence of anaphylactic shock in terms of the immunoglobulin antibodies.4 In 1921, Prausnitz and Kustner and non-immunoglobulin triggering events, and the demonstrated the ability to transfer a serum factor cellular events based on the rise in intracellular (termed reagin) in the serum of a sensitive patient cyclic AMP and calcium that release preformed to a non-sensitive recipient, although it was not granule-associated mediators and the rapidly until 1967 that Ishizaka and colleagues identified formed, newly synthesized mediators predo- this reagin as a new class of immunoglobulin minantly based on arachidonic acid metabolism. known as IgE. Finally, in 1975, Coombs and Gell These primary mediators recruit other cells with classified hypersensitivity reactions into three the release of secondary mediators that either immediate types and one delayed type, although potentiate or ultimately curtail the anaphylactic in practice these types need not necessarily occur reaction. The roles of these mediators in the various in isolation from each other.5 In immunological causes of cardiovascular collapse are examined. terms, anaphylaxis is an example of an immediate, The treatment of anaphylactic shock involves Type-1 hypersensitivity reaction. oxygen, adrenaline and fluids. The importance and safety of intravenous adrenaline are discussed. DEFINITION Combined Hi and H blocking antihistamines and Currently, the term anaphylaxis is best used to http://emj.bmj.com/ steroids have a limited role. Glucagon and other describe the rapid, generalized and often adrenergic drugs are occasionally used, and unanticipated, immunologically mediated events several new experimental drugs are being that occur after exposure to certain developed. foreign substances in sensitized Key words: adrenaline, anaphylactic shock, previously persons. Anaphylactoid reactions describe a clinically anaphylaxis, histamine H1 receptor blockaders, identical syndrome involving similar mediators but on September 24, 2021 by guest. Protected copyright. histamine H2 receptor blockaders not triggered by IgE antibody and not necessarily INTRODUCTION requiring previous exposure. Despite important aetiological distinctions, the term anaphylaxis is The first case of anaphylaxis was recorded on the commonly used to describe both of these clinical tomb of King Menes, an Egyptian Pharaoh who syndromes, even when the mechanisms are died suddenly in 2640 BC following a wasp sting.' unknown.3 The most common life-threatening The term anaphylaxis is derived from the Greek feature of acute anaphylaxis is cardiovascular and means literally 'against protection'.2 It was collapse or shock. Other life-threatening effects Correspondence: introduced in 1902 by Charles Richet and Paul include bronchospasm, angio-oedema and A.F.T. Brown, Portier following experiments with unexpected pulmonary oedema.6'7 This paper will focus on the Staff Specialist, fatal reactions on dogs sensitized to Portuguese mechanisms and both general and specific Department of man-of-war venom, observed the previous year treatment of anaphylactic shock. Emergency whilst on board Prince Albert of Monaco's yacht Medicine, Royal in the Brisbane Hospital, Mediterranean. Richet was subsequently awarded the Nobel Prize in Medicine and MECHANISMS OF Brisbane, ANAPHYLACTIC SHOCK Queensland 4029, Physiology in 1913.3 Australia At around the same time, in 1906, Von Pirquet Mechanisms of anaphylactic shock may be divided i 1994 Emergency Medicine A.F:T Brown into four main categories: the events that trigger the protein drugs acting as haptens such as antibiotics, anaphylactic reaction; the cellular events that then vitamins and steroids; vaccines; foods, including J Accid Emerg Med: first published as 10.1136/emj.12.2.89 on 1 June 1995. Downloaded from lead to mediator release; the clinical pharmacology milk, fish and nuts; venoms, particularly of of these mediators; and finally the cardiovascular Hymenoptera; and many other substances as responses of patients to these mediators. diverse as ethylene oxide, hydatid cysts and latex.8 Latex allergy was first reported in 1979, and has MECHANISMS: TRIGGERING caused intra-operative anaphylactic reactions.12 In EVENTS addition, allergy to the latex catheter-tip used in barium enemas has also been recorded, most The events that trigger anaphylaxis are either commonly in children with spina bifida or anaphylactic and IgE immunologically mediated, congenital urological abnormalities.13 or anaphylactoid and non-immunoglobulin mediated, although in many reactions there is ANAPHYLACTOID REACTIONS evidence of the involvement of multiple pathways (see Table 1). Anaphylactoid reactions are non-immunoglobulin mediated and are caused by mediator release that ANAPHYLACTIC IgE is triggered independently of reaginic antibodies. ANTIBODY REACTIONS These reactions do not require prior exposure, and patients may not react on every occasion. Most cases of anaphylaxis are IgE, or rarely IgG4, Anaphylactoid reactions may be due to mediated.8 Following previous exposure to an complement activation, coagulation/fibrinolysis antigen, IgE reaginic antibodies are released into system activation, or the direct pharmacological the circulation by plasma cells derived from B- release of mediators.8 lymphocytes, under the influence of helper T-cells. These antibodies bind to glycoprotein receptors COMPLEMENT ACTIVATION on tissue mast cells or blood-borne basophils, thereby sensitizing them. Subsequent re-exposure Complement activation via the classical pathway to the antigen cross-links the Fab portions of two or alternate pathway leads to the formation of surface-bound IgE molecules, activating the cell anaphylatoxins C3a, C4a and C5a. These and triggering the release of chemical mediators.9'10 anaphylatoxins stimulate mast cells and basophils In normal subjects there are up to 100 000 surface- to degranulate, releasing mediators that cause http://emj.bmj.com/ bound IgE molecules per mast cell, and in atopic local and systemic reactions. C3a and C5a also subjects up to half a million." directly induce increased vascular permeability, A vast range of substances induce IgE antibody smooth muscle contraction and neutrophil formation (see Table 2), including the following: chemotaxis.14,15 protein drugs such as insulin and ACTH; non- COAGU LATION/FI BRINOLYSIS on September 24, 2021 by guest. Protected copyright. Table 1. Causes of anaphylaxis/anaphylactoid SYSTEM ACTIVATION reactions Activation of the coagulation/fibrinolysis system Anaphylactic: IgE mediated via Hageman Factor XII leads either to plasmin See Table 2 production and activation of complement, or to the production of kinins such as bradykinin that cause Anaphylactoid: Non-IgE mediated (1) Complement activation vasodilatation and increased vascular (a) Classical pathway permeability.8"11 (b) Alternate pathway (2) Coagulation/fibrinolysis system activation DIRECT PHARMACOLOGICAL (3) Direct pharmacological release of mediators (a) Direct histamine release RELEASE OF MEDIATORS (b) Modulators of arachidonic acid metabolism The pharmacological release of mediators is seen (c) Sulphiting agents with opioids or radiocontrast media that release (4) Physical histamine directly.1'617 Alternatively, aspirin and (a) Exercise induced other non-steroidal anti-inflammatory drugs 90 (5) Idiopathic modulate arachidonic acid metabolism by 1994 Emergency Medicine Anaphylactic Table 2. Common causes of IgE (1) Protein drugs (hormones) shock: antibody formation J Accid Emerg Med: first published as 10.1136/emj.12.2.89 on 1 June 1995. Downloaded from Insulin, ACTH, vasopressin mechanisms and (2) Non-protein drugs (haptens) treatment (a) Antibiotics Penicillin, sulphonamides, cephalosporins (b) Vitamins Thiamine, folic acid (3) Vaccines (allergy probably to cultivating tissue) Pertussis, typhoid (4) Foods Eggs, fish, nuts, chocolate, fruits (5) Venoms Bee, wasp, fire ant, snake (6) Foreign protein agents Tetanus antitoxin, gamma globulin, venom antitoxin, semen (7) Enzymes Trypsin, chymotrypsin, penicillinase (8) Allergen extracts Pollen, mould, animal dander (9) Chemicals Ethylene oxide gas, formaldehyde (10) Parasites Hydatid cyst rupture (11) Latex Surgical gloves, catheter-tip interfering with the cyclo-oxygenase pathway, plasma histamine, suggesting that other equally leading to enhanced formation of lipoxygenase important mediators are involved. Mast cells and products such as the leukotrienes. Mast cell circulating basophils are the key cells in the allergic degranulation is not involved.'4 response, and produce two main groups of mediators following triggering.22 RARE, PHYSICAL AND http://emj.bmj.com/ IDIOPATHIC CAUSES PRIMARY, PREFORMED, Rare causes of anaphylactoid reactions include GRANULE-ASSOCIATED sulphiting agents used as food preservatives, and MEDIATORS exercise-induced anaphylaxis, first described in 1980, in which anaphylaxis is triggered by exertion, First, antigen cross links two surface-bound IgE on September 24, 2021 by guest. Protected copyright. or exertion following
Recommended publications
  • Differentiating Between Anxiety, Syncope & Anaphylaxis
    Differentiating between anxiety, syncope & anaphylaxis Dr. Réka Gustafson Medical Health Officer Vancouver Coastal Health Introduction Anaphylaxis is a rare but much feared side-effect of vaccination. Most vaccine providers will never see a case of true anaphylaxis due to vaccination, but need to be prepared to diagnose and respond to this medical emergency. Since anaphylaxis is so rare, most of us rely on guidelines to assist us in assessment and response. Due to the highly variable presentation, and absence of clinical trials, guidelines are by necessity often vague and very conservative. Guidelines are no substitute for good clinical judgment. Anaphylaxis Guidelines • “Anaphylaxis is a potentially life-threatening IgE mediated allergic reaction” – How many people die or have died from anaphylaxis after immunization? Can we predict who is likely to die from anaphylaxis? • “Anaphylaxis is one of the rarer events reported in the post-marketing surveillance” – How rare? Will I or my colleagues ever see a case? • “Changes develop over several minutes” – What is “several”? 1, 2, 10, 20 minutes? • “Even when there are mild symptoms initially, there is a potential for progression to a severe and even irreversible outcome” – Do I park my clinical judgment at the door? What do I look for in my clinical assessment? • “Fatalities during anaphylaxis usually result from delayed administration of epinephrine and from severe cardiac and respiratory complications. “ – What is delayed? How much time do I have? What is anaphylaxis? •an acute, potentially
    [Show full text]
  • CIRCULATORY COLLAPSE - EMERGENCY (ISS MED/3A - ALL/FIN) Page 1 of 2 Pages
    SHOCK - CIRCULATORY COLLAPSE - EMERGENCY (ISS MED/3A - ALL/FIN) Page 1 of 2 pages NOTE The most critical step is identifying and treating the underlying cause. Basic causes of shock are: Anaphylaxis - severe allergic reaction Heart attack Loss of circulating blood volume (bleeding, burns, dehydration) Decompression sickness Venous dilation (allergy, pain, drugs, heat stroke, infection) High or low body temperature SIGNS Pulse - rapid, weak, thready Respiration - shallow, irregular, labored Blood Pressure - low, falling Mental State - confused, sluggish, anxious Eyes - pupils may be dilated Skin - cold, clammy, sweating If no pulse or respiration, perform {CARDIOPULMONARY RESUSCITATION: CPR - EMERGENCY} (SODF: ISS MED: EMERGENCY). 1. Evaluate vital signs and record every 5 minutes every 5 minutes. Time (minutes) 0 5 10 15 20 25 30 ALSP Blood Presssure (ALSP-4) Pulse Respiratory Rate ALSP Temperature (Assessment-4) ALSP Pulse Oximeter (Assessment-3) 2. Unstow and don Non-Sterile Gloves (ALSP Airway-4,5,6). If bleeding, control by applying direct pressure using Gauze Pads (Airway-11). 3. Prevent loss of body heat with clothing, sleeping bag, warm environment. 24 AUG 00 4044.shock.circ.collapse.em.doc SHOCK - CIRCULATORY COLLAPSE - EMERGENCY (ISS MED/3A - ALL/FIN) Page 2 of 2 pages 4. Attach ECG leads. Refer to {CARDIOPULMONARY RESUSCITATION: CPR - ECG DATA STORAGE - EMERGENCY} (SODF: ISS MED: EMERGENCY). 5. Contact Surgeon. 6. If no immediate ground communication available, start IV with 1L bag Normal Saline. Fully open roller clamp assembly to allow maximum flow. Refer to {INJECTIONS - NONPOWERED INTRAVENOUS FLUID INFUSION} (SODF: ISS MED: INJECTIONS/IV). 24 AUG 00 4044.shock.circ.collapse.em.doc.
    [Show full text]
  • Circulatory Collapse During Wound Closure In
    Zhang et al. BMC Anesthesiology (2021) 21:4 https://doi.org/10.1186/s12871-020-01220-6 CASE REPORT Open Access Circulatory collapse during wound closure in spine surgery with an unknown cause: a possible adverse effect of topical application of vancomycin? Xiaoqing Zhang, Wenwen Zhai, Min Li and Xiangyang Guo* Abstract Background: Vancomycin (VCM) is effective in fighting Gram-positive bacteria related severe infections, and topical application of VCM powder is widely used in orthopedic surgery to prevent wound infection. However, VCM could lead to infusion rate-dependent antibody-and complement-independent anaphylaxis reaction by inducing direct release of histamine. Case presentation: We retrospectively analyzed seven cases of severe hypotension and shock during wound closure or immediately after orthopedic surgery with unidentifiable reasons. We found that these cases were all associated with local application of VCM powder during wound closure process. Two patients experienced sudden cardiac arrest. Most of the cases (6/7) with circulatory collapse were discharged without severe sequelae. While one case with application of 3 g VCM developed cardiac arrest and remained in a coma due to hypoxic-hypoxic encephalopathy. The clinical presentations and the time of the shock onset were considered to be related with a VCM induced anaphylaxis reaction. However, as this was a retrospective study, and there was no laboratory examination performed, the conclusion was made upon differential diagnosis based on clinical manifestations and the timing of the shock. Conclusions: Local application of VCM may not be as safe as was once believed and may lead to a related anaphylaxis. As VCM induced infusion-rate dependent, non-IgE mediated anaphylaxisischaracterizedbydelayed occurrence, severe hypotension and even circulatory collapse, surgeons and anesthesiologists should be extra vigilant during and after VCM application.
    [Show full text]
  • Impact of Intra-Aortic Balloon Support on Endothelial Function and Tissue Perfusion Markers in Severe Heart Failure
    Central Journal of Cardiology & Clinical Research Bringing Excellence in Open Access Research Article *Corresponding author Silvia Gelás Lage, Instituto do Coração, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Impact of Intra-Aortic Balloon Universidade de Sao Paulo, Sao Paulo, SP, Brazil, Av. Dr. Enéas de Carvalho Aguiar, 44, 05403-000 - São Support on Endothelial Paulo, SP, Brazil, Tel: (55-11) 26615302; Email: Submitted: 12 September 2018 Accepted: 03 October 2018 Function and Tissue Perfusion Published: 05 October 2018 Copyright Markers in Severe Heart © 2018 Lage et al. OPEN ACCESS Failure Keywords • Intra-aortic balloon pump; Severe heart failure; Antônio A. P. Fagundes Júnior, Liliane Kopel, Claudia Bernoche, Endothelial function; Central venous oxygen saturation; Arteriovenous carbon dioxide gradient; Milena F. Macatrão-Costa, Leonardo N. Lopes, Antonio P. B-type natriuretic peptide Mansur, and Silvia Gelás Lage* Heart Institute, Hospital das Clinicas HCFMUSP, Brazil Abstract Background: The intra-aortic balloon pump (IABP) is a common therapy available for ventricular support in critical cardiac patients. The aim of this study was to characterize the effect of IABP on endothelial function, on serum B-type natriuretic peptide (BNP) levels and on central venous oxygen saturation (ScVO2) and arteriovenous carbon dioxide gradient (∆PCO2) as perfusion tissue markers. Methods and results: Twenty-three patients with severe heart failure, mean age 50±13 years, left ventricular ejection fraction of 22±8% were included. All were on IABP support and the protocol considered 3 conditions: 1) IABP ratio 1:1, 2) IABP ratio 1:3 and 3) IAPB ratio 1:1. The period of time between conditions was 20 minutes.
    [Show full text]
  • Shock and Circulatory Support
    17 Emerg Med J: first published as 10.1136/emj.2003.012450 on 20 December 2004. Downloaded from REVIEW Critical care in the emergency department: shock and circulatory support C A Graham, T R J Parke ............................................................................................................................... Emerg Med J 2005;22:17–21. doi: 10.1136/emj.2003.012450 Effective resuscitation includes the rapid identification and will produce organ failure and, in the context of global hypoperfusion, multiple organ failure correction of an inadequate circulation. Shock is said to be ensues. The aim of resuscitation is to prevent present when systemic hypoperfusion results in severe shock worsening and to restore the circulation to dysfunction of the vital organs. The finding of normal a level that meets the body’s tissue oxygen requirements. haemodynamic parameters, for example blood pressure, Shock can arise through a variety of mechan- does not exclude shock in itself. This paper reviews the isms. Pump failure may be attributable to pathophysiology, resuscitation, and continuing inadequate preload (for example, severe bleed- ing), myocardial failure, or excessive afterload. management of the patient presenting with shock to the Shock can also occur with an adequate or emergency department. increased cardiac output as seen in distributive ........................................................................... shock (for example, septic or anaphylactic shock). Vital tissues remain ischaemic as much of the cardiac output
    [Show full text]
  • Postinduction Paced Pulseless Electrical Activity in a Patient with a History of Oropharyngeal Instrumentation– Induced Reflex Circulatory Collapse
    CASE REPORT Ochsner Journal 16:315–320, 2016 Ó Academic Division of Ochsner Clinic Foundation Postinduction Paced Pulseless Electrical Activity in a Patient With a History of Oropharyngeal Instrumentation– Induced Reflex Circulatory Collapse Ryan J. Kline, MD,1 Ky Pham, MD,1 Carmen L. Labrie-Brown, MD,1 Ken Mancuso, MD,1 Paul LeLorier, MD,2 James Riopelle, MD,1 Alan David Kaye, MD, PhD1 1Department of Anesthesiology, Louisiana State University Health Sciences Center, New Orleans, LA 2Department of Internal Medicine, Louisiana State University Health Sciences Center, New Orleans, LA Background: Reflex hypotension and bradycardia have been reported to occur following administration of several drugs associated with administration of anesthesia and also following a variety of procedural stimuli. Case Report: A 54-year-old postmenopausal female with a history of asystole associated with sedated upper gastrointestinal endoscopy and post–anesthetic-induction tracheal intubation received advanced cardiac resuscitation after insertion of a temporary transvenous pacemaker failed to prevent pulseless electrical activity. The patient’s condition stabilized, and she underwent successful cataract extraction, intraocular lens implantation, and pars plana vitrectomy. Conclusion: Cardiac pacemaker insertion prior to performance of a procedure historically associated with reflex circulatory collapse can be expected to protect a patient from bradycardia but not necessarily hypotension. Keywords: Anesthesia–general, heart arrest, pacemaker–artificial, shock Address correspondence to Alan David Kaye, MD, PhD, Professor and Chairman, Department of Anesthesiology, Louisiana State University Health Sciences Center, 1542 Tulane Ave., Room 656, New Orleans, LA 70112. Tel: (504) 568-2319. Email: [email protected] INTRODUCTION during 2 upper gastrointestinal (GI) endoscopic examina- Reflex hypotension and bradycardia have been reported tions under IV sedation without topical anesthesia.
    [Show full text]
  • UK Comparative Audit of Upper Gastrointestinal Bleeding and the Use of Blood
    British Society of Gastroenterology UUKK CCoommppaarraattiivvee AAuuddiitt ooff UUppppeerr GGaassttrrooiinntteessttiinnaall BBlleeeeddiinngg aanndd tthhee UUssee ooff BBlloooodd DDeecceemmbbeerr 2 2000077 St. Elsewhere's Hospital National Comparative Audit of Blood Transfusion TABLE OF CONTENTS Acknowledgements Executive summary 4 Introduction 9 Why is this audit necessary? 9 Aims 9 What does this audit want to report? 10 What does this report include? 10 Who are the principal stakeholders? 10 Methods How were NHS trusts recruited? 11 Nature and size of the case sample for this audit 11 Pilot 11 Audit standards and criteria 11 Data collection 12 Audit report 12 How to read this report 13 The 1993/4 audit of acute upper gastrointestinal haemorrhage 14 Initial results of the UK audit of UGI bleeding and the use of blood 2007 15 Section 1 Principal Findings 17 Section 2 Organisational of Care 21 Section 3 Presentation and Initial care 27 Section 4 Patient Descriptors 33 Section 5 Endoscopy 35 Section 6 Additional Medical Management 43 Section 7 Surgery and Radiology 45 Section 8 Blood Transfusion 48 Section 9 Outcomes 52 Recommendations 54 Action Points 55 Discussion 56 Conclusions 58 References 59 Appendices 1 Participating hospitals i 2 Audit standards vii 3 Rockall score calculator xi 4 Audit questionnaires xii St. Elsewhere s Hospital 2 Acknowledgements We wish to thank all those who have participated in the UK Comparative Audit of Upper Gastrointestinal Bleeding and the Use of Blood. We recognise that this audit required an enormous amount of time and effort from many staff in each participating hospital, and are extremely grateful to everyone who took part for providing what we hope will be useful, meaningful data both at local and national level.
    [Show full text]
  • Cardiac Arrest During Anesthesia W
    130 Vol. 76, No. 3 Cardiac Arrest During Anesthesia W. H. CASSELS, M.D., San Mateo, and NYLA R. ELNES, M.D., Montreal, Canada circumstances, respiratory arrest may persist from SUMMARY perhaps two to twelve minutes before irreversible In cases of acute cardiac arrest from tran- damage results, because the oxygen in the lungs and sient or reversible causes resuscitation is a blood acts as a reservoir. On the other hand, cardiac distinct possibility. Prompt action is of the arrest will probably result in some irreversible dam- utmost importance. age in from two to four minutes. To counteract res- The sequelae of cardiac arrest will depend piratory arrest by artificial respiration requires only on the degree of anoxia that has developed moments because the respiratory mechanism is ac- and the amount of irreversible damage to cessible. To counteract circulatory arrest by man- brain tissue. Efficient manual artificial circu- ual circulation is likely to require minutes. The lation, begun immediately, can prevent such margin of safety in this condition is much narrower. damage. It is fairly obvious that if the heart fails because Four cases of cardiac arrest are described. of irreversible contributing circumstances such as Sudden circulatory collapse, which may or severe hemorrhage, shock, or embolus, efforts at may not imply cardiac arrest, is not uncom- cardiac resuscitation are well-nigh hopeless. On the mon during surgical procedures. Usually the other hand, in cases of acute cardiac arrest from patient recovers quickly when treatment is transient or reversible causes, resuscitation is a dis- prompt. tinct possibility and any restorative measure, no matter how drastic, is justifiable.
    [Show full text]
  • Trauma and Heart Disease
    Case Western Reserve Law Review Volume 5 Issue 2 Article 3 1954 Trauma and Heart Disease Alan R. Moritz Follow this and additional works at: https://scholarlycommons.law.case.edu/caselrev Part of the Law Commons Recommended Citation Alan R. Moritz, Trauma and Heart Disease, 5 W. Rsrv. L. Rev. 133 (1954) Available at: https://scholarlycommons.law.case.edu/caselrev/vol5/iss2/3 This Article is brought to you for free and open access by the Student Journals at Case Western Reserve University School of Law Scholarly Commons. It has been accepted for inclusion in Case Western Reserve Law Review by an authorized administrator of Case Western Reserve University School of Law Scholarly Commons. 1954] Trauma and Heart Disease by Alan R. Moritz WITH LEGAL ANNOTATIONS BY OLIVER SCHROEDER, JR.* D IFFERENCES of opinion in respect to the part played by trauma or stress in the causation of heart disease or in the causation of the failure of the diseased heart are responsible for an enormous volume of litigation. It is dear from reviewing the evidence presented before workman's compen- sation boards and trial courts in such cases that many attorneys know too little about the causal rela- tionships that may or may not exist and that many AUTHOR (B.S., 1920, M.A., 1921, M.D., TiM of 1923, University of Nebraska) is Professor Pathology and Director of the Institute of Path- doctors are insufficiently ology at Western Reserve University. His writ- critical in distinguishing ings have appeared in many legal and medical between medical possi- journals. bility and medical proba- bility.
    [Show full text]
  • Needle Decompression for Tension Pneumothorax: Clinical Correlation with Catheter Length Can J Surg
    INTERNATIONAL TRAUMA LIFE SUPPORT NEEDLE DECOMPRESSION OF TENSION PNEUMOTHORAX Roy Alson, MD, PhD, FACEP, FAAEM and Sabina Braithwaite, MD, MPH, FACEP The guidelines and references contained in this document are current as of the date of publication and in no way replace physician medical oversight. INTRODUCTION The purpose of this document is to update International Trauma Life Support (ITLS) instructors and providers of the position of ITLS in regard to the needle decompression of tension pneumothorax. The seventh edition of the ITLS Provider manual includes additional locations at which a needle decompression of a tension pneumothorax can be carried out beyond the traditional anterior location of the 2nd intercostal space in the mid-clavicular line. A number of other texts, including several used in the tactical medical environment, recommend performing decompression at either the 3rd or 4th intercostal space laterally. These apparently conflicting recommendations have led to confusion on the part of some ITLS instructors and providers with respect to the proper location for needle chest decompression of a tension pneumothorax. BACKGROUND A tension pneumothorax results when air enters the pleural space and is under pressure so that it causes the lung on the affected side to collapse. As a result, the lung is not able to exchange air with the environment and this leads to hypoventilation and hypoxemia. As the pressure rises in the affected hemithorax, the mediastinum can be shifted away from the side of injury and this can cause the vena cava to be compressed. As a result, little to no blood flows back into the heart, resulting in an obstructive or mechanical shock.
    [Show full text]
  • Characterization, Prevalence, and Risk Factors of Spontaneous And
    Louisiana State University LSU Digital Commons LSU Doctoral Dissertations Graduate School 2013 Characterization, prevalence, and risk factors of spontaneous and experimental atherosclerosis and vascular imaging in psittaciformes Hugues Beaufrère Louisiana State University and Agricultural and Mechanical College, [email protected] Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_dissertations Part of the Veterinary Medicine Commons Recommended Citation Beaufrère, Hugues, "Characterization, prevalence, and risk factors of spontaneous and experimental atherosclerosis and vascular imaging in psittaciformes" (2013). LSU Doctoral Dissertations. 1598. https://digitalcommons.lsu.edu/gradschool_dissertations/1598 This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in LSU Doctoral Dissertations by an authorized graduate school editor of LSU Digital Commons. For more information, please [email protected]. CHARACTERIZATION, PREVALENCE, AND RISK FACTORS OF SPONTANEOUS AND EXPERIMENTAL ATHEROSCLEROSIS AND VASCULAR IMAGING IN PSITTACIFORMES A Dissertation Submitted to the Graduate Faculty of the Louisiana State University and Agricultural and Mechanical College in partial fulfillment of the requirements for the degree of Doctor of Philosophy in The Department of Veterinary Clinical Sciences by Hugues Beaufrère Dr.Med.Vet., University of Lyon, France, 2006 Diplomate ABVP – Avian Practice, 2012 Diplomate ECZM (Avian), 2012 May 2013 A Mélanie, qui élève mon cœur. ii ACKNOWLEDGEMENTS First and foremost, I would like to express my thanks to my mentors, Drs. Thomas Tully and Javier Nevarez. Their help, guidance, and trust were instrumental in the completion of my program and these research projects. They promoted unique opportunities at LSU that were far beyond what was just required to succeed in this program.
    [Show full text]
  • Cardiac Arrhythmias in Acute Coronary Syndromes: Position Paper from the Joint EHRA, ACCA, and EAPCI Task Force
    FOCUS ARTICLE Euro Intervention 2014;10-online publish-ahead-of-print August 2014 Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force Bulent Gorenek*† (Chairperson, Turkey), Carina Blomström Lundqvist† (Sweden), Josep Brugada Terradellas† (Spain), A. John Camm† (UK), Gerhard Hindricks† (Germany), Kurt Huber‡ (Austria), Paulus Kirchhof† (UK), Karl-Heinz Kuck† (Germany), Gulmira Kudaiberdieva† (Turkey), Tina Lin† (Germany), Antonio Raviele† (Italy), Massimo Santini† (Italy), Roland Richard Tilz† (Germany), Marco Valgimigli¶ (The Netherlands), Marc A. Vos† (The Netherlands), Christian Vrints‡ (Belgium), and Uwe Zeymer‡ (Germany) Document Reviewers: Gregory Y.H. Lip (Review Coordinator) (UK), Tatjania Potpara (Serbia), Laurent Fauchier (France), Christian Sticherling (Switzerland), Marco Roffi (Switzerland), Petr Widimsky (Czech Republic), Julinda Mehilli (Germany), Maddalena Lettino (Italy), Francois Schiele (France), Peter Sinnaeve (Belgium), Giueseppe Boriani (Italy), Deirdre Lane (UK), and Irene Savelieva (on behalf of EP-Europace, UK) Introduction treatment. Atrial fibrillation (AF) may also warrant urgent treat- It is known that myocardial ischaemia and infarction leads to severe ment when a fast ventricular rate is associated with hemodynamic metabolic and electrophysiological changes that induce silent or deterioration. The management of other arrhythmias is also based symptomatic life-threatening arrhythmias. Sudden cardiac death is largely on symptoms rather than to avert
    [Show full text]